Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.8860
-0.0040 (-0.45%)
Jun 19, 2026, 5:35 PM CET
Biosynex Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -58.22 | -43.33 | -36.95 | 15.66 | 104 |
Depreciation & Amortization | 12.41 | 11.73 | 12.2 | 21.36 | 2.04 |
Other Amortization | 16.34 | - | - | - | - |
Loss (Gain) From Sale of Assets | -7.35 | 0.57 | -0.02 | -0.01 | 0.03 |
Asset Writedown & Restructuring Costs | 21.28 | 8.8 | 1.26 | - | - |
Other Operating Activities | 2.85 | -0.78 | -0.66 | 5.19 | 3.18 |
Change in Other Net Operating Assets | 6.8 | 12.9 | 14.51 | -37.26 | 0.58 |
Operating Cash Flow | -5.89 | -10.12 | -9.65 | 4.95 | 109.83 |
Operating Cash Flow Growth | - | - | - | -95.50% | 247.17% |
Capital Expenditures | -2.69 | -4.84 | -39.54 | -37.77 | -19.02 |
Sale of Property, Plant & Equipment | 0.77 | 1.25 | 0.08 | 0.05 | 0.04 |
Cash Acquisitions | -0.05 | -1.01 | -16.05 | -9.74 | -10.96 |
Investment in Securities | 5.01 | - | - | - | - |
Other Investing Activities | -0 | - | 0.71 | 0.69 | 0.97 |
Investing Cash Flow | 3.04 | -4.6 | -54.81 | -46.77 | -28.96 |
Short-Term Debt Issued | 0.01 | - | - | - | - |
Long-Term Debt Issued | - | 0.16 | 22.41 | 17.66 | 24.25 |
Total Debt Issued | 0.01 | 0.16 | 22.41 | 17.66 | 24.25 |
Long-Term Debt Repaid | -0.99 | -4.25 | -14.83 | -5.57 | -7.42 |
Net Debt Issued (Repaid) | -0.98 | -4.09 | 7.58 | 12.09 | 16.83 |
Issuance of Common Stock | 7.99 | - | - | - | 19.43 |
Repurchase of Common Stock | - | - | -3.22 | -1.73 | -20.08 |
Common Dividends Paid | - | - | - | -20.44 | -1.94 |
Other Financing Activities | -0.1 | - | 0.81 | -0.73 | 0.16 |
Financing Cash Flow | 6.91 | -4.09 | 5.17 | -10.81 | 14.4 |
Foreign Exchange Rate Adjustments | -0.25 | 3.29 | - | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
Net Cash Flow | 3.81 | -15.52 | -59.3 | -52.64 | 95.27 |
Free Cash Flow | -8.57 | -14.96 | -49.2 | -32.83 | 90.82 |
Free Cash Flow Growth | - | - | - | - | 303.29% |
Free Cash Flow Margin | -9.01% | -14.79% | -52.91% | -16.70% | 23.74% |
Free Cash Flow Per Share | -0.47 | -1.39 | -4.59 | -3.19 | 8.74 |
Levered Free Cash Flow | 14.17 | -6.27 | -45.97 | -26.31 | 72.74 |
Unlevered Free Cash Flow | 16.95 | -4.18 | -44.67 | -26 | 72.96 |
Change in Working Capital | 6.8 | 12.9 | 14.51 | -37.26 | 0.58 |